Literature DB >> 30363396

The Diagnostic Accuracy of Parkinson's Disease Mild Cognitive Impairment Battery Using the Movement Disorder Society Task Force Criteria.

Ondrej Bezdicek1, Tomas Nikolai1, Jiri Michalec2, Filip Růžička1, Petra Havránková1, Jan Roth1, Robert Jech1, Evžen Růžička1.   

Abstract

BACKGROUND: The aim of the present study was to provide empirical evidence regarding the classification accuracy of the International Parkinson and Movement Disorder Society (MDS) neuropsychological battery (NB) in the determination of Parkinson's disease mild cognitive impairment (PD-MCI).
METHODS: The present cross-sectional study included 106 PD patients subjected to PD-MCI classification at Level I and 120 healthy controls (HCs). All HC and PD subjects were then assessed with MDS-NB at Level II and matched according to age and education using different thresholds (1.5 and 2.0 standard deviations [SDs] below average).
RESULTS: We found that Level I and II resulted in different classifications of PD-MCI status. Detection thresholds of -1.5 SD and -2.0 SDs at Level II had also a significant impact on the discriminative validity of all measures in the MDS neuropsychological battery, based on area under the curve analyses. Overall, semantic fluency showed the highest potential in all comparisons not only between PD-MCI and HC, but also between PD-MCI and PD with no deficit (PD-ND).
CONCLUSIONS: Our results show that the battery at Level II is applicable and that some measures, such as semantic fluency, have high discriminative validity in the detection of PD-MCI versus PD-ND and HCs.

Entities:  

Keywords:  Parkinson's disease; mild cognitive impairment; validity

Year:  2016        PMID: 30363396      PMCID: PMC6174468          DOI: 10.1002/mdc3.12391

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  46 in total

1.  Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden; Bryan Bernard; Bichun Ouyang; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

2.  Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.

Authors:  Eva Pirogovsky; Dawn M Schiehser; Kristalyn M Obtera; Mathes M Burke; Stephanie L Lessig; David D Song; Irene Litvan; J Vincent Filoteo
Journal:  Neuropsychology       Date:  2014-01-13       Impact factor: 3.295

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Mental symptoms in Parkinson's disease are important contributors to caregiver distress.

Authors:  D Aarsland; J P Larsen; K Karlsen; N G Lim; E Tandberg
Journal:  Int J Geriatr Psychiatry       Date:  1999-10       Impact factor: 3.485

5.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

6.  Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited.

Authors:  Kolbjørn Brønnick; Guido Alves; Dag Aarsland; Ole-Bjørn Tysnes; Jan Petter Larsen
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

7.  Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.

Authors:  Roberta Biundo; Luca Weis; Manuela Pilleri; Silvia Facchini; Patrizia Formento-Dojot; Annamaria Vallelunga; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2013-03-13       Impact factor: 3.575

8.  Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.

Authors:  Gisela Llebaria; Javier Pagonabarraga; Jaime Kulisevsky; Carmen García-Sánchez; Berta Pascual-Sedano; Alexandre Gironell; Mercè Martínez-Corral
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

9.  Toward the processing speed theory of activities of daily living in healthy aging: normative data of the Functional Activities Questionnaire.

Authors:  Ondrej Bezdicek; Hana Stepankova; Lenka Martinec Novakova; Miloslav Kopecek
Journal:  Aging Clin Exp Res       Date:  2015-08-01       Impact factor: 3.636

10.  The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

Authors:  Caroline H Williams-Gray; Sarah L Mason; Jonathan R Evans; Thomas Foltynie; Carol Brayne; Trevor W Robbins; Roger A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-18       Impact factor: 10.154

View more
  6 in total

1.  Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison.

Authors:  Ondrej Bezdicek; Markéta Červenková; Tyler M Moore; Hana Stepankova Georgi; Zdenek Sulc; David A Wolk; Daniel A Weintraub; Paul J Moberg; Robert Jech; Miloslav Kopecek; David R Roalf
Journal:  Assessment       Date:  2018-06-21

2.  Separate neural representations of depression, anxiety and apathy in Parkinson's disease.

Authors:  Rotem Dan; Filip Růžička; Ondrej Bezdicek; Evžen Růžička; Jan Roth; Josef Vymazal; Gadi Goelman; Robert Jech
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

3.  Parkinson's Disease-Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge.

Authors:  Davide Maria Cammisuli; Salvatore Massimiliano Cammisuli; Jonathan Fusi; Ferdinando Franzoni; Carlo Pruneti
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

4.  The Instrumental Activities of Daily Living in Parkinson's Disease Patients Treated by Subthalamic Deep Brain Stimulation.

Authors:  Ondrej Bezdicek; Josef Mana; Filip Růžička; Filip Havlik; Anna Fečíková; Tereza Uhrová; Evžen Růžička; Dušan Urgošík; Robert Jech
Journal:  Front Aging Neurosci       Date:  2022-06-17       Impact factor: 5.702

5.  Anxiety disorders are associated with verbal memory impairment in patients with Parkinson's disease without dementia.

Authors:  Nadeeka N Dissanayaka; Elana J Forbes; Ji Hyun J Yang; Dana Pourzinal; John D O'Sullivan; Leander K Mitchell; David A Copland; Katie L McMahon; Gerard J Byrne
Journal:  J Neurol       Date:  2021-08-04       Impact factor: 4.849

6.  Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson's disease.

Authors:  Brenna A Cholerton; Kathleen L Poston; Laurice Yang; Liana S Rosenthal; Ted M Dawson; Alexander Pantelyat; Karen L Edwards; Lu Tian; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Shu-Ching Hu; Thomas J Montine; Cyrus P Zabetian
Journal:  J Clin Exp Neuropsychol       Date:  2021-08-06       Impact factor: 2.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.